San Francisco, CA, United States of America

Alex Goldberg

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gilead Sciences, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Goldberg. Retrieved from https://idiyas.com/inventor/alex-goldberg-ysonc2vx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alex Goldberg - Innovator in Therapeutic Compounds

Introduction

Alex Goldberg is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of therapeutic compounds, showcasing his expertise through his innovative patent.

Latest Patents

Goldberg holds a patent titled "Methods and intermediates for preparing therapeutic compounds." This patent relates to methods and intermediates useful for preparing a compound of formula I, or a co-crystal, solvate, salt, or combination thereof. His work in this area demonstrates his commitment to advancing medical science.

Career Highlights

Goldberg is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on cutting-edge research and development in the pharmaceutical industry. With 1 patent to his name, he has established himself as a valuable contributor to the field.

Collaborations

Throughout his career, Goldberg has collaborated with notable colleagues, including Sachin Dhar and Lars V Heumann. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Alex Goldberg is a dedicated inventor whose work in therapeutic compounds is paving the way for advancements in medicine. His contributions through patents and collaborations highlight his importance in the biopharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…